ATIF IQBAL to Disease-Free Survival
This is a "connection" page, showing publications ATIF IQBAL has written about Disease-Free Survival.
Connection Strength
0.143
-
A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer. 2021 03; 20(1):1-19.
Score: 0.077
-
Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer. 2018 09 01; 124(17):3510-3519.
Score: 0.067